OncLive TV

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Search Videos by Topic or Participant

Short, focused interviews with key oncology thought leaders. This unique platform allows oncology professionals to learn about important developments directly from their peers.

Dr. Ocean Discusses the Use of ctDNA in Pancreatic Cancer

Dr. Bryce on Potential Biomarkers of Response to Immunotherapy in Prostate Cancer

Dr. Castle on Minimally Invasive Surgical Approaches in RCC

Dr. Piotrowska on Treatment for EGFR-Mutant NSCLC

Dr. Garfall on Quadruplet Regimen in Multiple Myeloma

Dr. Robson on Differences Between Biosimilars and Biologics in Oncology

Dr. Braunstein on Reclassifying Ultra High-Risk Smoldering Multiple Myeloma

Dr. Shah on Biomarkers in Gastric/GEJ Cancer

Dr. Chaft on Investigational Neoadjuvant Immunotherapy Approaches in NSCLC

Next Page >>

Hundreds of the top oncologists and cancer researchers have conducted interviews with OncLive, which has contributed to a library of thousands of videos. To browse these interviews by the oncologist's names, click here >>>

Featured

ESMO Data Show More Can Be Done for Cancer of Unknown Primary Patients

Two research papers presented by Roche and Foundation Medicine at the 2019 European Society of Medical Oncology Annual Meeting demonstrate both the promise of an innovative precision medicine driven clinical trial (CUPISCO) for patients with cancer of unknown primary, as well as the challenges of identifying eligible patients for the trial.

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approvals in MCL and Beta Thalessemia-Associated Anemia, Priority Review in HCC, and More